Cargando…

Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis

We evaluated the cost-utility of replacing trivalent influenza vaccine (TIV) with quadrivalent influenza vaccine (QIV) in the current target populations in Uruguay. An existing decision-analytic static cost-effectiveness model was adapted for Uruguay. The population was stratified into age groups. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bianculli, Pablo Manuel, Bellier, Lucile, Mangado, Ignacio Olivera, Pérez, Carlos Grau, Mieres, Gustavo, Lazarov, Luis, Petitjean, Audrey, Dibarboure, Hugo, Lopez, Juan Guillermo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Influenza – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225211/ https://www.ncbi.nlm.nih.gov/pubmed/35344679 http://dx.doi.org/10.1080/21645515.2022.2050653

Ejemplares similares

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay
por: Arbo, Antonio, et al.
Publicado: (2022)

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
por: Wei, Xia, et al.
Publicado: (2023)

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico
por: Ruiz-Palacios, Guillermo M., et al.
Publicado: (2019)

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
por: Chen, Jianmin, et al.
Publicado: (2023)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
por: Hadigal, Sanjay, et al.
Publicado: (2022)

Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine
por: Olivera, Ignacio, et al.
Publicado: (2020)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
por: Kalappanavar, Nijalingappa K., et al.
Publicado: (2022)

Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2018)

Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system
por: Betancourt-Cravioto, Miguel, et al.
Publicado: (2021)

Cost minimization analysis of a hexavalent vaccine in Argentina
por: Olivera, Ignacio, et al.
Publicado: (2023)

Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity
por: Chowell, Gerardo, et al.
Publicado: (2012)

Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial
por: Huang, Xiaoyuan, et al.
Publicado: (2022)

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population
por: Tavares, Diana, et al.
Publicado: (2022)

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?
por: Raude, Jocelyn, et al.
Publicado: (2010)

Identification of Influenza Cases During the H1N1 Pandemic in Massachusetts Using Population-Based Hospital Discharge Data
por: Placzek, Hilary, et al.
Publicado: (2011)

Applying a New Model for Sharing Population Health Data to National Syndromic Influenza Surveillance: DiSTRIBuTE Project Proof of Concept, 2006 to 2009
por: Olson, Donald R, et al.
Publicado: (2011)

Prevalence and risk factors for swine influenza virus infection in the English pig population
por: Mastin, Alexander, et al.
Publicado: (2011)

Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
por: Fedichev, Peter, et al.
Publicado: (2011)

Top-hits for H1N1pdm Identified by Virtual Screening Using Ensemble-based Docking
por: Nguyen, Hung, et al.
Publicado: (2011)

The severity of pandemic H1N1 influenza in the United States, April – July 2009
por: Presanis, Anne M, et al.
Publicado: (2010)

Next Generation Syndromic Surveillance: Molecular Epidemiology, Electronic Health Records and the Pandemic Influenza A (H1N1) Virus
por: Rabadan, Raul, et al.
Publicado: (2009)

Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza
por: Le, Ly, et al.
Publicado: (2011)

Can Reactive School Closures help critical care provision during the current influenza pandemic?
por: House, Thomas, et al.
Publicado: (2009)

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza
por: Ross, Ted, et al.
Publicado: (2010)

Recovery of H14 influenza A virus isolates from sea ducks in the Western Hemisphere
por: Nolting, Jacqueline, et al.
Publicado: (2012)

Influenza activity in Saint Joseph, Missouri 1910-1923: Evidence for an early wave of the 1918 pandemic
por: Hoffman, Brian L.
Publicado: (2011)

Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA.
por: Ross, Ted M., et al.
Publicado: (2011)

Swine to human transmission of reassortants of pandemic (H1N1) 2009 and endemic swine influenza viruses: Abstract
por: de Silva, U. Chandimal, et al.
Publicado: (2011)

Fatal cases associated with pandemic influenza A (H1N1) reported in Greece.
por: Athanasiou, Maria, et al.
Publicado: (2010)

VirSim - a Model to Support Pandemic Policy Making
por: Fasth, Tobias, et al.
Publicado: (2010)

Weekly influenza-like-Illness rates were significantly lower in areas where schools were not in session in the United States during the 2009 H1N1 pandemic.
por: Briffault, Olivia
Publicado: (2011)

Critical paths in a metapopulation model of H1N1: Efficiently delaying influenza spreading through flight cancellation
por: Marcelino, Jose, et al.
Publicado: (2012)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

The early diversification of influenza A/H1N1pdm
por: Nelson, Martha, et al.
Publicado: (2009)

Quantifying the transmissibility of human influenza and its seasonal variation in temperate regions
por: Truscott, James, et al.
Publicado: (2010)

Public preparedness guidance for a severe influenza pandemic in different countries: a qualitative assessment and critical overview
por: Alonso, Wladimir J., et al.
Publicado: (2010)

Efficient simulation of the spatial transmission dynamics of influenza
por: Tsai, Meng-Tsung, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qom14pfb6uhsl5n0gf4co965uf